ClassID:

21647

A61K2300/00 - page 42 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#12301
20100105683
2010-04-29

COMPOUNDS USEFUL FOR INHIBITING CHK1

#12302
20100105649
2010-04-29

VETERINARY COMPOSITIONS FOR TREATING MASTITIS

#12303
20100105644
2010-04-29

BOTANICAL COMPOSITION FOR ENHANCED SKIN REPAIR AND USES THEREOF

#12304
20100105643
2010-04-29

Ophthalmic composition

#12305
20100105632
2010-04-29

Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals

#12306
20100105621
2010-04-29

Therapies for acute renal failure

#12307
20100105614
2010-04-29

ULTRA LOW DOSE DOXEPIN AND METHODS OF USING THE SAME TO TREAT SLEEP DISORDERS

#12308
20100105605
2010-04-29

Fatty acid formulations and oral delivery of proteins and peptides, and uses thereof

#12309
20100104696
2010-04-29

Nutritional composition with improved digestibility

#12310
20100104686
2010-04-29

Nutritional composition to promote healthy development and growth

#12311
20100104675
2010-04-29

Method Of Treating Demyelinating Central Nervous System Diseases

#12312
20100104670
2010-04-29

Use of chitosans for the treatment of nail inflammatory diseases

#12313
20100104664
2010-04-29

TREATMENT OF CHRONIC RENAL FAILURE AND OTHER CONDITIONS IN DOMESTIC ANIMALS: COMPOSITIONS AND METHODS

#12314
20100104663
2010-04-29

REHYDRATION COMPOSITION FOR PREPARING A SOLUTE BY RECONSTITUTION IN WATER

#12315
20100104661
2010-04-29

DISCONTINUOUS METHODS OF TREATING CANCER

#12316
20100104660
2010-04-29

Targeting cancer therapy combination

#12317
20100104644
2010-04-29

Compositions and Methods for Treating or Preventing Ophthalmic Disease

#12318
20100104642
2010-04-29

Hydrophilic foam and pharmaceutical dosage form employing the same

#12319
20100104639
2010-04-29

Bupropion hydrobromide and therapeutic applications

#12320
20100104638
2010-04-29

EXTENDED RELEASE ORAL ACETAMINOPHEN/TRAMADOL DOSAGE FORM

#12321
20100104624
2010-04-29

COMBINATION THERAPY USING PHOSPHODIESTERASE INHIBITORS

#12322
20100104621
2010-04-29

TREATING ADHD AND OTHER DISEASES INVOLVING INFLAMMATION

#12323
20100104592
2010-04-29

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

#12324
20100104586
2010-04-29

Treatment of carcinomas with a combination of EGF-pathway and telomerase inhibitors

#12325
20100104578
2010-04-29

METHOD AND COMPOSITION FOR TREATMENT OF NEOPLASMS

#12326
20100104574
2010-04-29

Frizzled-binding agents and uses thereof

#12327
20100104570
2010-04-29

Semaphorin 7A plays a critical role in TGF-β-induced pulmonary fibrosis and alveolar destruction

#12328
20100104567
2010-04-29

PHARMACEUTICAL COMPOSITION

#12329
20100104566
2010-04-29

ANTITUMOR COMBINATION COMPRISING A MORPHOLINYL ANTHRACYCLINE AND AN ANTIBODY

#12330
20100104565
2010-04-29

COMBINATIONS COMPRISING DMXAA FOR THE TREATMENT OF CANCER

#12331
20100104552
2010-04-29

ANTIBIOTIC SYNERGISM

#12332
20100104549
2010-04-29

Treatment of cancer with glufosfamide in patients not receiving insulin therapy

#12333
20100104547
2010-04-29

TOPICAL COMPOSITION FOR THE TREATMENT OF ALLERGENIC EFFECTS

#12334
20100104545
2010-04-29

Nutritional composition to promote healthy development and growth

#12335
20100104541
2010-04-29

Method for preventing and treating cardiovascular diseases with BRCA1

#12336
20100104540
2010-04-29

METHODS AND COMPOSITIONS FOR TREATMENT OF FIBROSIS

#12337
20100104538
2010-04-29

Beneficial effects of bacteriophage treatments

#12338
20100104534
2010-04-29

HYDRAZIDO-PEPTIDES AS INHIBITORS OF HCV NS3-PROTEASE

#12339
20100104515
2010-04-29

Use of alpha-hydroxy carbonyl compounds as reducing agents

#12340
20100100035
2010-04-22

Uterine stimulant sticks

#12341
20100099772
2010-04-22

METHODS, COMPOSITIONS, AND KITS FOR TREATING PAIN AND PRURITIS

#12342
20100099766
2010-04-22

Topical NSAID compositions having sensate component

#12343
20100099765
2010-04-22

Compositions, methods, and kits for polyunsaturated fatty acids from microalgae

#12344
20100099762
2010-04-22

COMBINATION THERAPY

#12345
20100099758
2010-04-22

Regenerative wound healing using copper-silver citrate composition

#12346
20100099742
2010-04-22

Sensitizing Cells for Apoptosis by Selectively Blocking Cytokines

#12347
20100099735
2010-04-22

METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION

#12348
20100099721
2010-04-22

NOVEL COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

#12349
20100099714
2010-04-22

AMPA and NMDA Receptor Antagonists for Neurodegenerative Diseases

#12350
20100099711
2010-04-22

Methods and Compositions Using Immunomodulatory Compounds for The Treatment and Management of Cancers and Other Diseases

#12351
20100099707
2010-04-22

Method for treating pulmonary arterial hypertension

#12352
20100099700
2010-04-22

HYDROGENATED PYRIDO (4,3-B) INDOLES FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)

#12353
20100099693
2010-04-22

NEW COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS

#12354
20100099666
2010-04-22

PHENOTHIAZINE MODULATORS OF H1 RECEPTOR AND D2 RECEPTOR

#12355
20100099651
2010-04-22

PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS

#12356
20100099650
2010-04-22

NASAL SPRAY COMPOSITION AND METHOD FOR TREATING RHINITIS, SINUSITIS OR BOTH

#12357
20100099647
2010-04-22

Aqueous Iron Carbohydrate Complexes, Their Production And Medicaments Containing Them

#12358
20100099645
2010-04-22

Compositions containing PUFA and methods of use thereof

#12359
20100099642
2010-04-22

TGF-BETA STIMULANT AND FURTHER AGENT TO REDUCE SIDE EFFECTS

#12360
20100099638
2010-04-22

Immunocompetent xenograft model

#12361
20100099636
2010-04-22

Hydrous gel and production process and use of the hydrous gel

#12362
20100099635
2010-04-22

Method for treating cystic fibrosis

#12363
20100099622
2010-04-22

Wound healing

#12364
20100099607
2010-04-22

Casein complexes

#12365
20100099606
2010-04-22

Effective use method of medicaments and method of preventing expression of side effect

#12366
20100099605
2010-04-22

Chaperonin 10 immunosuppression

#12367
20100099602
2010-04-22

PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE FOR THE PREVENTION AND TREATMENT OF HYPOXIC INJURY

#12368
20100098791
2010-04-22

COMPOSITION FOR TREATING XEROSTOMIA OR DRY MOUTH

#12369
20100098790
2010-04-22

Combination herbal product to benefit respiratory tract

#12370
20100098786
2010-04-22

FORMULATION CONTAINING A CARBOXYLIC ACID OR AN ESTER THEREOF

#12371
20100098783
2010-04-22

Appetite suppressant composition

#12372
20100098779
2010-04-22

COMPOSITIONS AND METHODS FOR PROPHYLACTIC AND THERAPEUTIC SUPPLEMENTATION OF NUTRITION IN SUBJECTS

#12373
20100098770
2010-04-22

SIROLIMUS PHARMACEUTICAL FORMULATIONS

#12374
20100098758
2010-04-22

Abuse-Resistant Dosage Form

#12375
20100098750
2010-04-22

Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent

#12376
20100098746
2010-04-22

COMPOSITIONS AND METHODS FOR TREATING PERIODONTAL DISEASE COMPRISING CLONIDINE, SULINDAC AND/OR FLUOCINOLONE

#12377
20100098720
2010-04-22

Substance preventing adverse actions of therapeutic agents for dyslipidemia

#12378
20100098715
2010-04-22

ANNEXIN II COMPOSITIONS FOR TREATING OR MONITORING INFLAMMATION OR IMMUNE-MEDIATED DISORDERS

#12379
20100098713
2010-04-22

27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor

#12380
20100098707
2010-04-22

Monoclonal antibodies that recognize epitopes of amyloid-beta

#12381
20100098702
2010-04-22

METHOD OF TREATING ANDROGEN INDEPENDENT PROSTATE CANCER

#12382
20100098701
2010-04-22

Combination of anti-CTLA4 antibody with dasatinib for the treatment of proliferative diseases

#12383
20100098696
2010-04-22

Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment

#12384
20100098691
2010-04-22

COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT

#12385
20100098690
2010-04-22

PHARMACEUTICAL COMPOSITION

#12386
20100098677
2010-04-22

Methods and devices for epithelial protection during photodynamic therapy

#12387
20100098676
2010-04-22

Synergistic anti-inflammatory and antioxidant dietary supplement compositions

#12388
20100098673
2010-04-22

BONE GRAFT COMPOSITES AND METHODS OF TREATING BONE DEFECTS

#12389
20100098671
2010-04-22

COMPOSITION FOR PREVENTION OR TREATMENT OF BONE MARROW DAMAGE

#12390
20100098668
2010-04-22

Oncolytic Adenoviruses and Uses Thereof

#12391
20100098665
2010-04-22

Method of cancer treatment

#12392
20100098660
2010-04-22

Method of treating tuberculosis with interferons

#12393
20100098657
2010-04-22

Method of Treating Cancer with Immunomodulatory Compounds and IgG

#12394
20100098654
2010-04-22

TREATMENT OF NEUROBLASTOMA WITH MULTI-ARM POLYMERIC CONJUGATES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN

#12395
20100098645
2010-04-22

FORMULATION AND METHOD FOR THE TREATMENT OF FUNGAL NAIL INFECTIONS

#12396
20100096330
2010-04-22

Method of determining a phosphorus binder dosage for a dialysis patient

#12397
20100096240
2010-04-22

Passenger conveyor handrail drive control strategy

#12398
20100093985
2010-04-15

USE OF AT LEAST ONE CYTOSOLIC PHOSPHOLIPASE A2 INHIBITOR AS A MEDICINE FOR SYMPTOMATIC TREATMENT OF MUCOVISCIDOSIS

#12399
20100093870
2010-04-15

HERBAL MEDICAMENTS FOR THE TREATMENT OF NEUROCEREBROVASCULAR DISORDERS

#12400
20100093861
2010-04-15

TREATMENT OF INSULIN RESISTANCE OR DISEASES ASSOCIATED WITH INSULIN RESISTANCE

#12401
20100093855
2010-04-15

Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia

#12402
20100093853
2010-04-15

Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes

#12403
20100093839
2010-04-15

Oligomeric compounds for the modulation of HIF-1alpha expression

#12404
20100093832
2010-04-15

Modulation of insulin like growth factor I receptor expression in cancer

#12405
20100093827
2010-04-15

METHOD FOR TOPICAL TREATMENT OF TAR-RESPONSIVE DERMATOLOGICAL DISORDERS

#12406
20100093797
2010-04-15

Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate

#12407
20100093783
2010-04-15

Compositions for treatment of common cold

#12408
20100093762
2010-04-15

METHODS FOR TREATING OR PREVENTING SYMPTOMS OF HORMONAL VARIATIONS

#12409
20100093755
2010-04-15

Ketoconazole enantiomer in humans

#12410
20100093754
2010-04-15

Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual Disorders

#12411
20100093750
2010-04-15

Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitors

#12412
20100093712
2010-04-15

Two-component pharmaceutical composition for the treatment of pain

#12413
20100093701
2010-04-15

COMBINATION THERAPY COMPRISING ANGIOTENSIN RECEPTOR BLOCKERS AND VASOPRESSIN RECEPTOR ANTAGONISTS

#12414
20100093692
2010-04-15

PIPERIDINYL-PIPERIDINE AND PIPERAZINYL-PIPERIDINE FOR USE IN THE TREATMENT OF DIABETES OR PAIN

#12415
20100093683
2010-04-15

Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor

#12416
20100093681
2010-04-15

Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor

#12417
20100093680
2010-04-15

Use of 3-alpha-androstanediol in combination with a 5-HT1a agonist, in the treatment of sexual dysfunction

#12418
20100093679
2010-04-15

DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY

#12419
20100093678
2010-04-15

Compositions and methods of the treatment of obesity and osteoporosis

#12420
20100093673
2010-04-15

PAIN RELIEVING PATCH

#12421
20100093667
2010-04-15

SALTS OF HIV INHIBITOR COMPOUNDS

#12422
20100093664
2010-04-15

Compositions useful for reducing nephrotoxicity and methods of use thereof

#12423
20100093652
2010-04-15

Preservative System for Emulsion-Based Therapeutic Topical Formulations

#12424
20100093649
2010-04-15

Synthetic glycolipid analogues and derivatives for the treatment of pathologic disorders

#12425
20100093648
2010-04-15

TREATMENT OF MACULAR DEGENERATION-RELATED DISORDERS

#12426
20100093647
2010-04-15

MGMT inhibitor combination for the treatment of neoplastic disorders

#12427
20100093626
2010-04-15

PEPTIDE AND SMALL MOLECULE AGONISTS OF EPHA AND THEIR USES IN DISEASE

#12428
20100093616
2010-04-15

Combination of EGF/GHRP-6 for Neurogeneration of Central Nervous System Following Autoimmune Damage

#12429
20100093614
2010-04-15

Novel Composition for Tumor Growth Control

#12430
20100093610
2010-04-15

ROMIDEPSIN-BASED TREATMENTS FOR CANCER

#12431
20100093603
2010-04-15

USE OF ORGANIC COMPOUNDS

#12432
20100093003
2010-04-15

Methods to impair hematologic cancer progenitor cells and compounds related thereto

#12433
20100092999
2010-04-15

Xanthurenic acid derivative pharmaceutical compositions and methods related thereto

#12434
20100092584
2010-04-15

Composition comprising the extract of combined herbs for preventing and treating liver disease

#12435
20100092582
2010-04-15

Topical hair care formulation and method of making

#12436
20100092580
2010-04-15

Weight reducing composition

#12437
20100092579
2010-04-15

Medicament for treating lung cancer

#12438
20100092577
2010-04-15

Topical compositions containing magaldrate

#12439
20100092573
2010-04-15

HEMOSTATIC BIO-MATERIAL COMPOSITION AND METHOD

#12440
20100092562
2010-04-15

SUSTAINED-RELEASE DRUG DELIVERY COMPOSITIONS AND METHODS

#12441
20100092561
2010-04-15

Methods of using substance P to promote healing of vascular wounds

#12442
20100092551
2010-04-15

Solid preparation comprising alogliptin and pioglitazone

#12443
20100092530
2010-04-15

Novel Triclosan Salts

#12444
20100092499
2010-04-15

Alpha Thymosin Peptides as Cancer Vaccine Adjuvants

#12445
20100092497
2010-04-15

METHODS OF IMMUNE OR HAEMATOLOGICAL ENHANCEMENT, INHIBITING TUMOUR FORMATION OR GROWTH, AND TREATING OR PREVENTING CANCER

#12446
20100092493
2010-04-15

Modulation of Complement System Activation for Treatment of Bleeding-Related Inflammation

#12447
20100092489
2010-04-15

Combination treatment of CD38-expressing tumors

#12448
20100092479
2010-04-15

Compositions and methods for treatment of viral diseases

#12449
20100092475
2010-04-15

Treatment method using EGFR antibodies and SRC inhibitors and related formulations

#12450
20100092474
2010-04-15

Pharmaceutical combinations

#12451
20100092473
2010-04-15

Anti-phospho-Akt antibodies

#12452
20100092469
2010-04-15

ANTAGONISTS OF A NON-SELECTIVE CATION CHANNEL IN NEURAL CELLS

#12453
20100092466
2010-04-15

COMBINATION OF ZD6474 AND BEVACIZUMAB FOR CANCER THERAPY

#12454
20100092465
2010-04-15

TREATMENT OF GRAFT-VERSUS-HOST DISEASE

#12455
20100092461
2010-04-15

Remedy For Chemotherapy-Resistant Cancer Containing HLA Class I-Recognizing Antibody as the Active Ingredient and Use of the Same

#12456
20100092454
2010-04-15

NOVEL USE OF ANTIDEPRESSANT COMPOUNDS AND RELATED COMPOSITIONS

#12457
20100092452
2010-04-15

Replenishment and enrichment of ocular surface lubrication

#12458
20100092451
2010-04-15

Combination enzyme therapy for digestion of dietary gluten

#12459
20100092450
2010-04-15

Use of hyaluronidase for the prevention or treatment of arterial hypertension or cardiac insufficiency

#12460
20100092447
2010-04-15

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF PRION DISEASES

#12461
20100092444
2010-04-15

Platelet rich plasma formulations for cardiac treatments

#12462
20100092441
2010-04-15

Use of nitrites and nitrates and compositions containing these

#12463
20100092430
2010-04-15

ATTENUATED ONCOLYTIC PARAMYXOVIRUSES ENCODING AVIAN CYTOKINES

#12464
20100092406
2010-04-15

Systems, Methods, and Compositions for Treatment and Use of a Palatal Patch

#12465
20100092399
2010-04-15

Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution

#12466
20100087547
2010-04-08

Use of a Blood-Flow Decrease Preventing Agent in Conjunction With Insufflating Gas

#12467
20100087546
2010-04-08

USE OF DIMETHYL SULFONE (MSM) TO REDUCE HOMOCYSTEINE LEVELS

#12468
20100087507
2010-04-08

Method of treating cancer with an RPN2 gene expression inhibitor

#12469
20100087501
2010-04-08

Highly Bioavailable Composition Containing Eprosartan-Poloxamer Complex or 2-(7-Chloro-5-Methyl-4-Oxo-3-Phenyl-4,5-Dihydro-3H-Pyridazine (4,5-b)Indol-1-yl)-N,N-Dimethylacetamide - Poloxamer Complex

#12470
20100087499
2010-04-08

PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING TEMOZOLOMIDE AND MULTI-TARGETED KINASE INHIBITORS

#12471
20100087498
2010-04-08

USE OF BIOTIN TO PREVENT PHOTOAGING

#12472
20100087493
2010-04-08

METHOD FOR IMPROVING THE PHARMACOKINETICS OF DRUGS METABOLIZED BY UGT2B10

#12473
20100087490
2010-04-08

Dosage units of 3-(6-(1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

#12474
20100087478
2010-04-08

HIF-1 Inhibitors

#12475
20100087473
2010-04-08

Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature

#12476
20100087470
2010-04-08

Buprenorphine-wafer for drug substitution therapy

#12477
20100087467
2010-04-08

Compositions useful as inhibitors of protein kinases

#12478
20100087450
2010-04-08

Organic compounds

#12479
20100087413
2010-04-08

Prevention and treatment of inflammation-induced and/or immune-mediated bone loss

#12480
20100087409
2010-04-08

COMPOSITION COMPRISING AN ANTIBIOTIC AND A CORTICOSTEROID

#12481
20100087405
2010-04-08

FOOD SUPPLEMENTATION COMPOSITION CONTAINING ONE OR MORE VITAMIN D3 COMPOUNDS AND ONE OR MORE MAGNESIUM SALTS

#12482
20100087404
2010-04-08

METHOD OF TREATING AND PREVENTING HYPERPARATHYROIDISM WITH ACTIVE VITAMIN D ANALOGS

#12483
20100087403
2010-04-08

Topical treatment of skin infection

#12484
20100087399
2010-04-08

USE OF 9-OXOACRIDINE-10-ACETIC ACID, SALTS AND ESTERS THEREOF IN COMBINATION THERAPY OF OVARIAN CANCER

#12485
20100087393
2010-04-08

Methods and compositions of inhibiting complement and cellular activation with Dextran Sulfate

#12486
20100087391
2010-04-08

TREATMENT OF INFLAMMATORY BOWEL DISEASE

#12487
20100087386
2010-04-08

Topical use of Levofloxacin for reducing lung inflammation

#12488
20100087375
2010-04-08

Modulation of synaptogenesis

#12489
20100087365
2010-04-08

Pharmaceutical Compositions of Hglp-1, Exendin-4 and Analogs Thereof

#12490
20100086647
2010-04-08

FEED OR FOOD PRODUCTS COMPRISING FUNGAL MATERIAL

#12491
20100086627
2010-04-08

Methods and formulations for treating chronic liver disease

#12492
20100086626
2010-04-08

Capsaicinoid decontamination compositions and methods of use

#12493
20100086625
2010-04-08

METHODS FOR TREATING SKIN LESIONS

#12494
20100086624
2010-04-08

COLON CLEANSING COMPOSITIONS AND METHODS

#12495
20100086593
2010-04-08

Dosage forms of bisphosphonates

#12496
20100086560
2010-04-08

CHEMOKINES AS ADJUVANTS OF IMMUNE RESPONSE

#12497
20100086554
2010-04-08

METHODS FOR ADMINISTERING ANTI-IL-5 ANTIBODIES

#12498
20100086553
2010-04-08

ANTITUMOR AGENT

#12499
20100086551
2010-04-08

ANTIBODY AND USES THEREOF

#12500
20100086550
2010-04-08

ANTICANCER AGENT COMPRISING ANTI-PD-1 ANTIBODY OR ANTI-PD-L1 ANTIBODY

#12501
20100086548
2010-04-08

Use of anti-IL-20 antibody for treating osteoporosis

#12502
20100086547
2010-04-08

METHODS FOR ADMINISTERING ANTI-IL-5 ANTIBODIES

#12503
20100086543
2010-04-08

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH CERAMIDE BIOSYNTHESIS

#12504
20100086542
2010-04-08

POTENTIATION OF ERYTHROPOIETIN (EPO) ACTION BY MEMBRANE STEROID RECEPTOR AGONISTS

#12505
20100086524
2010-04-08

CELLULAR PREPARATIONS FOR USE AS A REVASCULARIZATION STIMULATING AGENT

#12506
20100086519
2010-04-08

Treatment of Hepatitis C Infection With Metalloporphyrins

#12507
20100086517
2010-04-08

Enhancement of B cell proliferation by IL-15

#12508
20100086483
2010-04-08

METHOD OF MULTIDETECTOR COMPUTED TOMAGRAPHY

#12509
20100081985
2010-04-01

Platelet Additive Solution For Leukoreducing White Blood Cells In Apheresed Platelets

#12510
20100081862
2010-04-01

Composition and method to modify sperm function and increase male gender ratio in mammals

#12511
20100081723
2010-04-01

Memantine For The Treatment Of Childhood Behavioral Disorders

#12512
20100081722
2010-04-01

COMPOSITION AND METHOD FOR NEUROPROTECTION AGAINST EXCITOTOXIC INJURY

#12513
20100081718
2010-04-01

COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS

#12514
20100081713
2010-04-01

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS

#12515
20100081704
2010-04-01

Isoform of bruton's tyrosine kinase (BTK) protein

#12516
20100081694
2010-04-01

COMPOSITION COMPRISING AT LEAST ONE PPAR AGONIST AND A LIPID COMPONENT

#12517
20100081681
2010-04-01

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING AGE-RELATED DISEASES

#12518
20100081646
2010-04-01

Heteroarylalkoxy-substituted quinolone inhibitors of PDE4

#12519
20100081642
2010-04-01

CB-1 RECEPTOR MODULATOR PHARMACEUTICAL FORMULATIONS

#12520
20100081639
2010-04-01

PHARMACEUTICAL COMPOSITION COMPRISING FERMENTED GINSENG

#12521
20100081631
2010-04-01

METHODS AND COMPOSITIONS FOR TREATING GASTROINTENSTIAL DISORDERS

#12522
20100081630
2010-04-01

Heparin Compositions and Selectin Inhibition

#12523
20100081623
2010-04-01

NOVEL TELLURIUM COMPOUNDS AND THEIR USE AS IMMUNOMODULATORS

#12524
20100080863
2010-04-01

Dietary composition and method of using the same

#12525
20100080858
2010-04-01

Anti-hypothermia composition

#12526
20100080856
2010-04-01

Method and composition for postoperative wound healing

#12527
20100080846
2010-04-01

DIPYRIDAMOLE AND ACETYLSALICYLIC ACID FORMULATIONS AND PROCESS FOR PREPARING SAME

#12528
20100080837
2010-04-01

Method for reducing the risk of spontaneous abortion in a human female subject

#12529
20100080822
2010-04-01

Cinnamomi and poria composition, method to prepare same and uses thereof

#12530
20100080821
2010-04-01

Energy Compositions

#12531
20100080820
2010-04-01

Preparation of a therapeutic composition

#12532
20100080807
2010-04-01

Methods and Compositions for Treating Viral Hemorrhagic Fever

#12533
20100080797
2010-04-01

THERAPY PROCEDURE FOR DRUG DELIVERY FOR TRIGEMINAL PAIN

#12534
20100080788
2010-04-01

Alginate and alginate lyase compositions and methods of use

#12535
20100080781
2010-04-01

Preventing transfusion related complications in a recipient of a blood transfusion

#12536
20100080769
2010-04-01

Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies

#12537
20100080768
2010-04-01

Compositions and Methods for the Treatment of Inflammatory Dermatosis and Other Pathological Conditions of the Skin

#12538
20100080756
2010-04-01

Methods for protecting and regenerating bone marrow using CXCR3 agonists and antagonists

#12539
20100076094
2010-03-25

Formulation containing phosphate derivatives of electron transfer agents

#12540
20100076084
2010-03-25

Method of Treating Metabolic Disorders, Especially Diabetes, or a Disease or Condition Associated with Diabetes

#12541
20100076073
2010-03-25

Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders

#12542
20100076044
2010-03-25

Therapeutic agent for inflammatory bowel disease and TNF-α production inhibitor

#12543
20100076038
2010-03-25

Therapeutic agent for urinary excretion disorder

#12544
20100076035
2010-03-25

Transdermal drug delivery using an osmolyte and vasoactive agent

#12545
20100076009
2010-03-25

Adjuvant chemotherapy for anaplastic gliomas

#12546
20100076008
2010-03-25

Pharmaceutical compositions containing plasma protein

#12547
20100076002
2010-03-25

Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions and Pharmaceutical Compositions

#12548
20100075945
2010-03-25

GRAM-POSITIVE CARBAPENEM ANTIBACTERIALS AND PROCESSES FOR THEIR PREPARATION

#12549
20100075928
2010-03-25

CANCER TREATMENT METHOD

#12550
20100075925
2010-03-25

Hyperthermic technologies and therapeutic uses thereof

#12551
20100075906
2010-03-25

Targeted therapeutic proteins

#12552
20100075905
2010-03-25

Cellular factor-containing solution compositions

#12553
20100075900
2010-03-25

Use of Nutritional Compositions for Preventing Disorders

#12554
20100074978
2010-03-25

Method of treatment and prevention of metabolic and digestion disorders and of pathological states associated therewith and products used therein

#12555
20100074977
2010-03-25

Methods for treating glioblastoma with herbal compositions

#12556
20100074976
2010-03-25

NOVEL AGENTS FOR THE TREATMENT OF DISORDERS CONNECTED TO IMPAIRED NEUROTRANSMISSION

#12557
20100074973
2010-03-25

THIOXANTHENE MODULATORS OF DOPAMINE D2 RECEPTORS

#12558
20100074969
2010-03-25

METHOD OF CONTROLLING BLOOD SUGAR LEVELS, INSULIN LEVELS, CHOLESTEROL LEVELS, BODY FAT LEVELS, AND BODY WEIGHT BY ADMINISTERING A NUTRIENT FIBER MATRIX

#12559
20100074968
2010-03-25

Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s)

#12560
20100074964
2010-03-25

Super brown cream

#12561
20100074960
2010-03-25

High-loading, controlled-release magnesium oral dosage forms and methods of making and using same

#12562
20100074955
2010-03-25

Combination of NMDA-Receptor Ligand and a Compound With 5-HT6 Receptor Affinity

#12563
20100074950
2010-03-25

Anti-diabetic combinations

#12564
20100074949
2010-03-25

Pharmaceutical composition and administration thereof

#12565
20100074939
2010-03-25

HARMINE COMPOUNDS FOR PROMOTING BONE GROWTH

#12566
20100074934
2010-03-25

MEDICAL IMPLANTS WITH A COMBINATION OF COMPOUNDS

#12567
20100074933
2010-03-25

Cell and enzyme compositions for modulating ale acids, cholesterol and triglycerides

#12568
20100074909
2010-03-25

Combinations for the treatment of cancer

#12569
20100074902
2010-03-25

Methods for human allografting

#12570
20100074885
2010-03-25

Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase

#12571
20100074881
2010-03-25

MULTIPLE NEBULIZER SYSTEMS

#12572
20100074877
2010-03-25

COMPOSITION FOR IMPROVING SKIN QUALITY AND A PROCESS FOR PREPARING THE SAME

#12573
20100074876
2010-03-25

Calcium phosphate delivery vehicles for osteoinductive proteins

#12574
20100074875
2010-03-25

Neural cell proliferation induced through the culture of neural cells with umbilical cord blood-derived mesenchymal stem cells

#12575
20100074870
2010-03-25

Probiotic infant products

#12576
20100074853
2010-03-25

Compositions Comprising Kakadu Plum Extract Or Acai Berry Extract

#12577
20100074852
2010-03-25

Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors

#12578
20100069877
2010-03-18

APPARATUS AND METHOD TO DISPENSE HPC-BASED VISCOUS LIQUIDS INTO POROUS SUBSTRATES, E.G., CONTINUOUS WEB-BASED PROCESS

#12579
20100069501
2010-03-18

Pharmaceutical Composition Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol and Paracetamol

#12580
20100069486
2010-03-18

ANTI-TUMOR COMPOSITION

#12581
20100069482
2010-03-18

Gel useful for the delivery of ophthalmic drugs

#12582
20100069458
2010-03-18

COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER

#12583
20100069438
2010-03-18

ANESTHESIA INDUCTION AND MAINTENANCE DRUG

#12584
20100069411
2010-03-18

CANCER TREATMENT METHOD

#12585
20100069410
2010-03-18

ACYCLOVIR FORMULATIONS

#12586
20100069402
2010-03-18

Treatment of Behavioral Disorders

#12587
20100069398
2010-03-18

Combination therapy

#12588
20100069392
2010-03-18

Combination of HMG-COA Reductase Inhibitors with Phosphodiesterase 4 Inhibitors for the Treatment of Inflammatory Pulmonary Disease

#12589
20100069344
2010-03-18

SMALL MOLECULE ANTAGONISTS OF BCL2 FAMILY PROTEINS

#12590
20100069342
2010-03-18

Formoterol/steroid bronchodilating compositions and methods of use thereof

#12591
20100069340
2010-03-18

PHARMACEUTICAL COMPOSITIONS OF AN SRC KINASE INHIBITOR AND AN AROMATASE INHIBITOR

#12592
20100069335
2010-03-18

Prevention and Treatment of Ophthalmic Complications of Diabetes

#12593
20100069326
2010-03-18

Combination Therapies to Treat Cardio- and Cerebro-Vascular Disorders

#12594
20100069325
2010-03-18

Pharmaceutical composition for treatment of chronic liver diseases and use thereof

#12595
20100069320
2010-03-18

SYNERGISM OF GOS AND POLYFRUCTOSE

#12596
20100069318
2010-03-18

Combination of an HDAC inhibitor and an antimetabolite

#12597
20100069306
2010-03-18

Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders

#12598
20100069305
2010-03-18

Composition for maintaining gastrointestinal homeostasis

#12599
20100069298
2010-03-18

Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same

#12600
20100069291
2010-03-18

Combination comprising CNDAC (2′-cyano-2′-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosyl-cytosine) and a cytotoxic agent